Dergiler / Ulusal Travma ve Acil Cerrahi Dergisi / 2020 / Cilt: 26 - Sayı: 5

The efficacy of curcumin on PDGF expression and NF-kappa B pathway: TNBS-induced colitis

Kurkumin’in PDGF ekspresyonu ve NF-kappa B üzerindeki etkisi: TNBS kolit modeli

Sayfa
663–670
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: The effects of curcumin improved possibly by modulating the NF-κB signaling pathway should be considered against colitis alone or in combination with the conventional anti-colitic therapies in future studies.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:BACKGROUND: Curcumin is an antioxidant and anti-inflammatory molecule known to be a potent inhibitor of nuclear factor kappa B (NF-kappa B).
📊
Temel Bulgular & Veri:In this study, we aimed to investigate the therapeutic effects of curcumin on colitis induced by a 2,4,6-trinitrobenzene sulfonic acid (TNBS).
💡
Sonuç & Katkı:CONCLUSION: The effects of curcumin improved possibly by modulating the NF-κB signaling pathway should be considered against colitis alone or in combination with the conventional anti-colitic therapies in future studies.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

BACKGROUND: Curcumin is an antioxidant and anti-inflammatory molecule known to be a potent inhibitor of nuclear factor kappa B (NF-kappa B). In this study, we aimed to investigate the therapeutic effects of curcumin on colitis induced by a 2,4,6-trinitrobenzene sulfonic acid (TNBS). METHODS: After the induction of colitis under anesthesia, 42 rats were divided into six groups as follows; the curcumin oral group, curcumin (20 mg/kg); the corn oil oral group, corn oil (20 mg/kg) using gastric gavage, the curcumin rectal group, curcumin; the corn oil rectal group, corn oil; the control group, 1 mL saline solution (0.9% NaCl) were administered using the rectal route. In the sham group, only rectal catheterization was performed. At the end of the seven day, the blood and intestinal tissue samples were obtained for histopathological examination and for MPO, MDA, NO, PDGF, IL-6, TNF-alpha, NF-kappaB. RESULTS: The macroscopic damage score was significantly higher in curcumin oral, corn oil oral and saline groups when compared to the sham group (p<0.05). The significant differences between groups were evaluated using the biochemical analysis of intestinal tissue for IL-6, NO, NF-κB, PDGF, TNF-α, MDA, MPO (p<0.05). NF-κB levels of blood in curcumin oral, curcumin rectal, sham, corn oil oral, corn oil rectal groups were significantly increased when compared to saline rectal group (p≤0.001). NF-κB serum levels of corn oil rectal and control group (p≤0.001) were lower than the sham group (p=0.012). CONCLUSION: The effects of curcumin improved possibly by modulating the NF-κB signaling pathway should be considered against colitis alone or in combination with the conventional anti-colitic therapies in future studies.

Abstract

AMAÇ: Kurkumin, nükleer faktör kappa B’nin (NF-kappa B) güçlü bir inhibitörü olduğu bilinen antioksidan ve antienflamatuvar bir moleküldür. Kurkumin’in 2,4,6-trinitrobenzen sülfonik asit (TNBS) ile indüklenen kolit modeli üzerindeki etkisini araştırmayı amaçladık. GEREÇ VE YÖNTEM: Anestezi altında kolit indüksiyonundan sonra, 42 sıçan altı gruba ayrıldı; kurkumin oral grup, kurkumin (20 mg/kg); mısır yağı oral grubu, mısır yağı (20 mg/kg) mide gavajı yoluyla, kurkumin rektal grubu, kurkumin; mısır yağı rektal grubu, mısır yağı. Kontrol grubuna 1 mL salin solüsyonu (%0.9 NaCl) rektal yolla uygulandı. Sham grubunda sadece rektal kateterizasyon yapıldı. Yedi gün sonunda, histopatolojik inceleme ve MPO, MDA, NO, PDGF, IL-6, TNF-alfa, NF-kappa B için kan ve bağırsak doku örnekleri alındı. BULGULAR: Makroskobik hasar skoru, kurkumin oral, mısır yağı oral ve salin gruplarında sham grubuna göre anlamlı olarak yüksek bulundu (p<0.05). Gruplar arasındaki anlamlı fark, IL-6, NO, NF-kB, PDGF, TNF-α, MDA, MPO intestinal dokunun biyokimyasal analizinde değerlendirildi (p<0.05). Kurkumin oral, kurkumin rektal, sham, mısır yağı oral, mısır yağı rektal gruplarında NF-kB kan seviyeleri, salin rektal grubuna göre anlamlı olarak arttı (p=0.001). Mısır yağı rektal ve kontrol grubunun NF-kB serum seviyeleri (p≤0.001) sham grubundan düşük bulundu (p=0.012). TARTIŞMA: Kurkumin’in, NF-kB sinyal yolundaki duzenleyici etkisi muhtemelen iyileştirici özelliği ile gelecekteki çalışmalarda tek başına kolite karşı veya konvansiyonel anti-kolitik tedaviler de kombinasyon halinde düşünülmelidir.

🔖

Bu Makaleye Atıf Yap

ALTINEL, Y., YALÇIN, Ş., ERCAN, G., YAVUZ, E., ERÇETİN, C., GÜLÇİÇEK, O. B., ÇELİK, A., ÖZKAYA, G., UZUN, H. (2020). The efficacy of curcumin on PDGF expression and NF-kappa B pathway: TNBS-induced colitis. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 26 - Sayı: 5, 663–670. https://ajindex.com/articles/323474

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Sartor RB. Mucosal immunology and mechanisms of gastrointestinal inflammation. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Feldman M, Friedman LS, Brandt LJ, editors. Philadelphia, PA: WB Saunders; 2002. pp.21–51
  2. Topcu-Tarladacalisir Y, Akpolat M, Uz YH, Kizilay G, Sapmaz-Metin M, Cerkezkayabekir A, et al. Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: the roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Med Food 2013;16:296–305
  3. Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology 2004;126:1582–92
  4. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006;12:S3–9
  5. Calabrese V, Butterfield DA, Stella AM. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer’s disease. Ital J Biochem 2003;52:177–81
  6. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005;223:181–90
  7. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006;69:195–206
  8. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006;4:1502–6
  9. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 2005;11:1747–52
  10. Deguchi Y, Andoh A, Inatomi O, Yagi Y, Bamba S, Araki Y, et al. Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis. Dig Dis Sci 2007;52:2993–8
  11. Sanovic S, Lamb DP, Blennerhassett MG. Damage to the enteric nervous system in experimental colitis. Am J Pathol 1999;155:1051–7
  12. Lourenssen S, Wells RW, Blennerhassett MG. Differential responses of intrinsic and extrinsic innervation of smooth muscle cells in rat colitis. Exp Neurol 2005;195:497–507
  13. Marlow SL, Blennerhassett MG. Deficient innervation characterizes intestinal strictures in a